NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Massimo Puoti
Ospedale Niguarda Ca' Granda, Milan - Milano / Italy
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 5011618
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Massimo Puoti's MOST POPULAR ARTICLES
1-)
Statements from the Taormina expert meeting on occult hepatitis B virus infection Journal of hepatology 49 (4), 652-657, 2008
2-)
EASL recommendations on treatment of hepatitis C: final update of the series☆ Journal of hepatology 73 (5), 1170-1218, 2020
3-)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … The lancet Respiratory medicine 9 (12), 1407-1418, 2021
4-)
A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma International journal of cancer 75 (3), 347-354, 1998
5-)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 …VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ...The lancet Respiratory medicine 9 (12), 1407-1418, 20217362021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept